Why Is vTv Therapeutics (VTVT) Stock Down 46% Today?
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
VTv Therapeutics stock is falling on Monday as VTVT investors react to the company's cadisegliatin clinical program being put on hold.
The post Why Is vTv Therapeutics (VTVT) Stock Down 46% Today? appeared first on InvestorPlace.
More From InvestorPlace